The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Associations of Mortality With Ocular Disorders and an Interventionof High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
Open accessAbstract
OBJECTIVE: To assess the association of ocular disorders and high doses of antioxidants or zinc with mortality in the Age-Related Eye Disease Study (AREDS). METHODS: Baseline fundus and lens photographs were used to grade the macular and lens status of AREDS participants. Participants were randomly assigned to receive oral supplements of high-dose antioxidants, zinc, antioxidants plus zinc, or placebo. Risk of all-cause and cause-specific mortality was assessed using adjusted Cox proportional hazards models. RESULTS: During median follow-up of 6.5 years, 534 (11%) of 4753 AREDS participants died. In fully adjusted models, participants with advanced age-related macular degeneration (AMD) compared with participants with few, if any, drusen had increased mortality (relative risk [RR], 1.41; 95% confidence interval [CI], 1.08-1.86). Advanced AMD was associated with cardiovascular deaths. Compared with participants having good acuity in both eyes, those with visual acuity worse than 20/40 in 1 eye had increased mortality (RR, 1.36; 95% CI, 1.12-1.65). Nuclear opacity (RR, 1.40; 95% CI, 1.12-1.75) and cataract surgery (RR, 1.55; 95% CI, 1.18-2.05) were associated with increased all-cause mortality and with cancer deaths. Participants randomly assigned to receive zinc had lower mortality than those not taking zinc (RR, 0.73; 95% CI, 0.61-0.89). CONCLUSIONS: The decreased survival of AREDS participants with AMD and cataract suggests that these conditions may reflect systemic rather than only local processes. The improved survival in individuals randomly assigned to receive zinc requires further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Zinc alone has decreased the incidence of blindness due to age-related macular degeneration in 25% of these elderly subjects, and, most important, increased longevity has also been reported in those treated with zinc (41,42).”
From Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress (2007) · cites this paper as [42]
In the citing paper
“Zinc alone has decreased the incidence of blindness due to age-related macular degeneration in 25% of these elderly subjects, and, most important, increased longevity has also been reported in those treated with zinc (41,42).”
From Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress (2007) · cites this paper as [42]
In the citing paper
“Interestingly, only the zinc-supplemented group showed increased longevity (74). The risk of mortality was reduced by 27% in the Age-Related Eye Disease Study Group studies in subjects 55–81 y of age who received only therapeutic zinc daily.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.10.1417 · Cited by 3,285
Self-citationThe Age-Related Eye Disease Study (AREDS)
The Age-Related Eye Disease Study Research Group (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00031-8 · Cited by 596
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans
Ariyo, A. A., Haan, M. N., Tangen, C. M., Rutledge, J. C., Cushman, M., Dobs, A. S., & Furberg, C. D. (2000) · Circulation · doi:10.1161/01.cir.102.15.1773 · Cited by 556
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01218-1 · Cited by 556
Hypertension, cardiovascular disease, and age-related macular degeneration
Hyman, L. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.3.351 · Cited by 441
Age-related Macular Degeneration Is Associated with Atherosclerosis
Vingerling, J. R., Dielemans, I., Bots, M. L., Albert Hofman, D., Grobbee, D. E., & de Jong, P. T. V. M. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117648 · Cited by 351
Girodon, F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.7.748 · Cited by 292
Do age-related macular degeneration and cardiovascular disease share common antecedents?
Snow, K. K., & Seddon, J. M. (1999) · Ophthalmic Epidemiology · doi:10.1076/opep.6.2.125.1558 · Cited by 276
Association Between Depressive Symptoms and Mortality in Older Women
Whooley, M. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.19.2129 · Cited by 266
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00732-7 · Cited by 240
Research works printed but not linked: 1
- Food and Nutrition Board, National Academy of Sciences. Zinc. In: Dietary Ref- erence Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Io- dine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Wash- ington, DC: National Academy Press; 2002.
Cited by
Sorted by citations
Items 201–215 of 215
Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00006-9
Tumosa, N. (2012) · Pathy's Principles and Practice of Geriatric Medicine · doi:10.1002/9781119952930.ch85
Tsou, B. C., Liu, T. Y. A., Kong, J., Bressler, S. B., Arévalo, J. F., Brady, C. J., Handa, J. T., MEYERLE, C. B., Scott, A. W., Wenick, A. S., et al. (2021) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126421989228
Association of Age-Related Macular Degeneration With Mortality: A Propensity Score-Matched AnalysisPreprint
Chen, Y., Wang, Y., Shang, X., Wang, W., & Zhu, Z. (2022) · medRxiv · doi:10.1101/2022.01.18.22269511
Meleth, A. D., Raiji, V. R., Krishnadev, N., & Chew, E. Y. (2011) · Springer eBooks · doi:10.1007/978-3-642-20870-6_12
Abel, R. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50087-9
Abel, R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00066-2
Evans, J. R. (2007) · CRC Press eBooks · doi:10.1201/9781420043013.ch14
Mortality increased in those with age-related eye disease
(2004) · Nursing Standard · doi:10.7748/ns.18.47.10.s25
Retinal and Cardiovascular Diseases: The “Common Soil” Theory
Wong, T. Y. (2007) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v36n10(s1)ps4
Wu, H., Wang, X., Liu, Y., Ye, Z., Cheng, R., Su, M., Sun, X., & Jiang, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-80275-8
Lake, R., Liuzzi, J. P., & Yoo, C. (2025) · Journal of Trace Elements and Minerals · doi:10.1016/j.jtemin.2025.100233
Felfeli, T., Glazier, R. H., Gozdyra, P., Wilson, M. K., Presseau, J., & Brent, M. H. (2026) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2025.12.021
Bastawrous, A., Ouchtar, Y., Gichangi, M. M., Bitok, M., Rono, H. K., Keel, S., Foster, A., & Burton, M. J. (2026) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100800
Song, Y., Ji, H., Xie, D., Huang, F., & Yang, L. (2026) · Medicine · doi:10.1097/md.0000000000049604
Metadata
- Authors
- AREDS Research Group
- Affiliations
- Emmes (United States) (US)
- Corresponding author
- AREDS Research Group
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-05-01
- Volume
- 122
- Issue
- 5
- Pages
- 716
- ISSN
- 0003-9950 (ISSN-L)
- PMC
- PMC1473208
- OpenAlex
- W1548644132
- Cited by
- 215
- References
- 32
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 8 · 2018: 6 · 2017: 11 · 2016: 11 · 2015: 7 · 2014: 15 · 2013: 8 · 2012: 15
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1z01ey000394-01)
- National Eye Institute (Z01 EY000394-03)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Keywords
- eye diseases, mortality, age-related macular degeneration, drusen, visual acuity, nuclear lens opacity, cataract surgery, cataract, antioxidants, zinc supplementation, all-cause mortality, cardiovascular mortality, cancer mortality
- MeSH terms
- Aged, Aged, 80 and over, Aging, Antioxidants, Ascorbic Acid, Cataract, Cataract Extraction, Cause of Death, Drug Therapy, Combination, Female, Humans, Macular Degeneration, Male, Middle Aged, United States, Vision Disorders, Vitamin E, Zinc Oxide, Survival Rate, Proportional Hazards Models, beta Carotene, Visually Impaired Persons, Persons with Visual Disabilities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
